New York · 82164

Angiotensin L - Converting Enzyme (ace) Level in New York

New York Medicare Avg
$14.28
0% above national avg
National Medicare Avg
$14.24
All states combined
Billed Charge (NY)
$110.16
What providers submit
Est. Commercial (NY)
$35.71
National avg: $31.90
Est. Cash / Self-Pay (NY)
$41.01
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

3.8K
Services in NY
20
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New York

Provider Medicare Services
Northwell Health Laboratories $14.29 1.1K
Brodsky, Jordan M.D. $14.31 954
Sunrise Medical Laboratories, Inc. $14.31 791
Abraham, Tobin M.D. $14.31 209
Klein, Asaf M.D. $14.31 158
Kaplan, Stuart M.D. $14.31 115
Levine, Benjamin M.D. $14.31 113
Quality Healthcare Management Inc $14.31 92
Laboratory Alliance Of Central New... $13.43 90
Enzo Clinical Labs, Inc. $14.31 50
Mongroo, Rana $14.31 44
Lenco Diagnostic Laboratories,inc. $14.31 37
Empire City Laboratories, Inc $14.31 26
Sherman Abrams Laboratory Inc $14.31 26
Cohen, Daniel M.D. $14.31 23

New York Pricing in Context

In New York, CPT code 82164 (Angiotensin L - Converting Enzyme (ace) Level) carries an average Medicare payment of $14.28 — 0% above the national benchmark of $14.24. 20 providers across the state submitted claims for this procedure in 2023, performing 3.8K total services. Individual payments in NY ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New York is $110.16, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New York sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in New York lands near $35.71, with self-pay cash prices typically around $41.01. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Angiotensin L - Converting Enzyme (ace) Level cost in New York?

The average Medicare payment for Angiotensin L - Converting Enzyme (ace) Level in New York is $14.28, which is 0% above the national average of $14.24. Providers in NY typically bill $110.16 for this procedure.

What does Angiotensin L - Converting Enzyme (ace) Level cost with insurance in New York?

With commercial insurance in New York, Angiotensin L - Converting Enzyme (ace) Level costs an estimated $35.71. Without insurance, the estimated cash price is $41.01. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Angiotensin L - Converting Enzyme (ace) Level in New York?

20 providers in New York billed Medicare for Angiotensin L - Converting Enzyme (ace) Level in 2023, performing 3.8K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Angiotensin L - Converting Enzyme (ace) Level cheaper in New York than the national average?

No — Angiotensin L - Converting Enzyme (ace) Level costs 0% above the national average in New York. The state average Medicare payment is $14.28 compared to $14.24 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial